Marilynn Marchione

Latest in Home
The 2026 AI-Powered Financial Analysis Handbook
Sponsored
The 2026 AI-Powered Financial Analysis Handbook
July 31, 2026
Robot Expansion74846e78 9d6e 4ac4 Bb7b 52299e207b10
Fanuc's Michigan Expansion to Meet Domestic Robot Demand Gets Big Boost from State
August 3, 2026
Ep581
117-Year-Old Candy Company to Shutter Factory
August 3, 2026
Sign carrying the corporate logo stands outside a Nissan dealership Monday, July 27, 2026, in Highlands Ranch, Colo.
Nissan Returns to Profit but Warns of Middle East, China Woes
August 3, 2026
Related Stories
In this Dec. 18, 2019, photo, Toyota's human-shaped T-HR3 robot is remotely controlled by its staff member during a demonstration in Tokyo.
News
Toyota Upgrades its Humanoid Robot
Opengraph Fb
Manufacturing
Milwaukee Tool Plans to Build New Campus, Add 870 Jobs
Louie walks with the assistance of a cart UW-Madison students modified for him.
Medical
Engineering Students Modify Cart for Dog Born Without Front Legs
Practical AI Lessons and Strategies
Sponsor Content
Practical AI Lessons and Strategies
More from Marilynn Marchione
Financial Storytelling in the Age of AI
Sponsored
Financial Storytelling in the Age of AI
Transforming data-driven presentations into compelling stories that drive actual business decisions.
July 31, 2026
Food and Drug Administration campus in Silver Spring, Md., Oct. 14, 2015.
Medical
Panel Urges Rejection of Experimental Alzheimer's Drug
Advisers concluded there wasn’t enough evidence that the drug slowed the disease.
November 9, 2020
A Biogen scientist works on Alzheimer’s disease research in a laboratory at the drugmaker’s headquarters in Cambridge, Mass., Dec. 12, 2019.
Medical
FDA Panel Reviews 1st New Alzheimer's Drug in 2 Decades
One of the biggest drug decisions in decades is looming.
November 6, 2020
Scientists work with a bioreactor at a Regeneron Pharmaceuticals facility in New York state.
Medical
2nd COVID-19 Antibody Drug Study Has Setback
Independent monitors recommended halting enrollment of the most severely ill patients due to a potential safety problem.
November 2, 2020
Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead U.S. manufacturing site, March 2020.
Medical
FDA Approves First COVID-19 Drug
Remdesivir cut the time to recovery by an average of five days in a large study.
October 23, 2020
An undated image from video provided by Regeneron Pharmaceuticals shows vials inspected at the company's facilities in New York state, Oct. 2, 2020.
Medical
Antibody Drugs Are No Cure but Seem Promising for COVID-19
Eli Lilly and Regeneron have asked the Food and Drug Administration for emergency authorization.
October 9, 2020
Researchers prepare cells to produce possible COVID-19 antibodies for testing in a laboratory in Indianapolis, May 2020.
Medical
Lilly Seeks Emergency Use of Antibody Drug for COVID-19
Early results from a study that suggested the drug reduced symptoms, the amount of the virus, hospitalizations and ER visits.
October 7, 2020
A health care worker administers a COVID-19 test at the Martin Luther King, Jr. Clinica Campesina Health Center in Homestead, Fla., July 6, 2020.
Medical
Drug Shows Promise in 1st Largely Minority COVID-19 Study
Tocilizumab, sold as Actemra and RoActemra, treats rheumatoid arthritis and other diseases.
September 21, 2020
Eli Lilly & Co. corporate headquarters in Indianapolis, April 26, 2017.
Medical
Antibody Drug May Cut COVID-19 Hospitalizations
Eli Lilly said the results are an encouraging “proof of principle” as it and other studies continue.
September 16, 2020
A researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, May 2020.
Medical
Companies Test COVID-19 Antibody Drugs
With a vaccine still months off, companies are rushing to test what may be the next best thing.
August 12, 2020
A pharmacist holds a bottle of hydroxychloroquine in Oakland, Calif., April 6, 2020.
Medical
Study on Malaria Drug for Coronavirus Retracted
Independent reviewers were not able to verify information that’s been widely questioned by other scientists.
June 5, 2020
A pharmacist holds a bottle of hydroxychloroquine in Oakland, Calif., April 6, 2020.
Medical
Malaria Drug Fails to Prevent COVID-19 in Rigorous Study
Hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.
June 4, 2020
Gilead Sciences headquarters in Foster City, Calif., April 30, 2020.
Medical
Gilead Says Drug Helped Moderately Ill Coronavirus Patients
Remdesivir is the only treatment that’s been shown in a rigorous experiment to help fight the virus.
June 2, 2020
A bicyclist pedals past an entrance to a Moderna building, Cambridge, Mass., May 18, 2020.
Medical
Early Vaccine Results Encouraging, Company Says
Study volunteers had antibodies similar to those seen in people who have recovered from COVID-19.
May 19, 2020
Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site, March 2020.
Medical
US OKs 1st Drug Shown to Help Virus Recovery
The FDA cleared Gilead Science’s intravenous drug for hospitalized patients with "severe disease."
May 4, 2020